Literature DB >> 7888274

Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy.

H Y Hsu1, S Y Lin, C J Huang, S L Lian, Y H Ho.   

Abstract

Serum copper levels (SCL) and serum zinc levels (SZL) were evaluated in 128 patients with nasopharyngeal carcinoma (NPC) of varying stages before, during, and after radiotherapy, and then compared with normal age-matched subjects. Among these patients, there were 119 undifferentiated squamous cell carcinoma, 5 differentiated squamous cell carcinoma, and 4 moderately differentiated squamous cell carcinoma, respectively. Before radiotherapy, SCLs were significantly higher in NPC patients than in normal subjects, but the difference of SZLs was not significant. The ratio of Cu/Zn also showed a significant difference between normal subjects and NPC patients preradiotherapy. Moreover, except stage II, patients with more advanced stages of the disease had more elevated Cu/Zn ratios. During and after the period of radiotherapy, the SCL decreased as compared with the level of preradiotherapy. The Cu/Zn ratio also decreased after radiotherapy but not significant. However, Cu/Zn ratio of expired patients at least 2 yr after radiotherapy did not show the significant decrease in contrast to the alive ones.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888274     DOI: 10.1007/bf02790064

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  34 in total

Review 1.  Role of trace elements in cancer.

Authors:  M K Schwartz
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

2.  Significance of serum copper levels in adult patients with Hodgkin's disease.

Authors:  M Hrgovcic; C F Tessmer; F B Thomas; L M Fuller; J F Gamble; C C Shullenberger
Journal:  Cancer       Date:  1973-06       Impact factor: 6.860

3.  Serum copper/zinc ratio in oral carcinoma.

Authors:  I N Jha; H B Singh; N Prasad
Journal:  Indian J Med Res       Date:  1985-06       Impact factor: 2.375

4.  Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.

Authors:  A C Margerison; J R Mann
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

5.  Studies of plasma zinc, copper, caeruloplasmin, and growth hormone: with special reference to carcinoma of the bronchus.

Authors:  G S Andrews
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

6.  Plasma copper and zinc levels in patients with malignant tumors of digestive organs: clinical evaluation of the C1/Zn ratio.

Authors:  S Inutsuka; S Araki
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

7.  Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy.

Authors:  A Lightman; J M Brandes; N Binur; A Drugan; O Zinder
Journal:  Clin Chem       Date:  1986-01       Impact factor: 8.327

8.  Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma.

Authors:  G F Buccheri; B Violante; A M Sartoris; D Ferrigno; A Curcio; F Vola
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

9.  A study of zinc metabolism in alcoholic cirrhosis.

Authors:  P R Mills; G S Fell; R G Bessent; L M Nelson; R I Russell
Journal:  Clin Sci (Lond)       Date:  1983-05       Impact factor: 6.124

10.  Serum copper and zinc levels in melanoma patients.

Authors:  G L Fisher; L E Spitler; K L McNeill; L S Rosenblatt
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860

View more
  1 in total

Review 1.  GATA1 Activity Governed by Configurations of cis-Acting Elements.

Authors:  Atsushi Hasegawa; Ritsuko Shimizu
Journal:  Front Oncol       Date:  2017-01-09       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.